Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis

NCT01202500 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

302

Enrollment

OTHER

Sponsor class

Stopped Fansidar marketing discontinued

Conditions

Congenital Toxoplasmosis

Interventions

PROCEDURE: reducing treatment to 3 months
PROCEDURE: registered length of treatment

Sponsor

Centre Hospitalier Universitaire Dijon